The Escalator: Patrice Harris named medical editor-in-chief at Everyday Health
Plus, people move at Fingerpaint, Centogene and more.
Most recent articles by Ray Pelosi
Five things for pharma marketers to know: Friday, October 23, 2020
Final stage for Moderna’s COVID vaccine trial is fully enrolled; 29 out of 40 drugs used to treat coronavirus are in short supply; MM+M Media Summit is Nov. 12.
Wunderman Thompson launches push to communicate with late-stage breast cancer patients
The effort takes into account differences between these patients and oft-targeted early-stage ones.
Five things for pharma marketers to know: Thursday, October 22, 2020
Purdue Pharma pleads guilty; CDC: 300,000 more people died in the U.S. from January-October than recent years; Arthritis drug shows inconsistent results in treating COVID-19.
Five things for pharma marketers to know: Wednesday, October 21, 2020
CA, NY to review any federally approved COVID-19 vaccine; AstraZeneca coronavirus vaccine trial expected to resume soon; Lyra Health partners with meditation app Calm.
Zimmer Biomet attempts to ease concerns about joint surgery during the pandemic
“Don’t Let Pain Gain on You” targets patients and caregivers alike.
Five things for pharma marketers to know: Tuesday, October 20, 2020
Only 58% of Americans say they are likely to get a COVID-19 vaccine; CDC mandate strongly recommends mask wearing when traveling; UNICEF is buying and distributing more than half a billion single-dose syringes to prep for eventual COVID-19 vaccine.
Five things for pharma marketers to know: Monday, October 19, 2020
More than 25% of state legislators have accepted campaign contributions from pharma since 2019; Pfizer won’t seek emergency authorization of COVID vaccine until late Nov.; Study: Remdesivir failed to prevent deaths from virus.
Five things for pharma marketers to know: Friday, October 16, 2020
Ebola therapy approved by FDA for first time; Oxford scientists develop COVID-19 test that detects virus in five minutes; WHO: Lockdown should be last resort for handling COVID-19 outbreaks.
The Escalator: Jesse Kates returns to Neon as co-managing director
Plus, people moves at Woebot Health and SPI Pharma.
